KLRK1 and neoplasm: In the current study, the effects of IL24-NKG2D-Exo on cell viability were investigated using the CCK-8 assay, focusing particularly on the differential responses between non-tumor cells (293T) (Figure S2) and tumor cells (A549, HELA, MCF-7) (Figure 4F).